1 How to use NICE guidance to commission high-quality services
2 Acknowledgement We are grateful to the many organisations and individuals who have contributed to the development of this guide. A list of these contributors is available at National Institute for Health and Clinical Excellence, All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations is permitted without the express written permission of NICE.
3 Foreword Being a world class commissioner means using the best evidence to specify and procure services that deliver improved outcomes for patients and populations, which provide a high-quality experience and deliver value for money for taxpayers. To do this commissioners need to place themselves at the centre of their local health economies and use their influential position as the local leaders of the NHS to shape the services they commission. Using NICE guidance, and in particular NICE clinical and public health guidance, should be the starting point for commissioners looking to ensure their populations get the healthcare that best meets their needs. NICE guidance is seen worldwide as the standard setter for effective health services. Commissioners will want to make sure that they and their partners have systems in place to optimise use of NICE guidance throughout the commissioning process. NICE guidance can help to support the commissioning of new services, the evaluation or redesign of existing services and the decommissioning of ineffective interventions. This How to guide outlines how NICE guidance supports the commissioning of high-quality services, and describes how the guidance can be used throughout the commissioning cycle. It also describes the support available from NICE and how using NICE guidance can support the achievement of world class commissioning competencies. It s a must read for all those involved in commissioning services across health and social care and will prove a really valuable resource for board members. Gary Belfield Acting Director General for Commissioning and System Management Department of Health
4 Contents Foreword 3 Part 1 Why has NICE produced this guide? 6 Who is this guide for? What is this guide for? Part 2 How can PCT boards support the use of NICE guidance? 8 Why should PCT boards support the use of NICE guidance? How can PCT boards assess whether NICE guidance is being used? Part 3 How can NICE guidance help you? 12 Why use NICE guidance in commissioning? What guidance does NICE produce? NICE s topic selection process Using NICE guidance to assess needs and set priorities Managing the financial impact of NICE guidance Using quality standards in your commissioning process The role of the Care Quality Commission
5 Part 4 NICE guidance and the commissioning cycle 20 Strategic planning Specifying outcomes and procuring services Managing demand and performance Patient and public involvement Building NICE guidance into your commissioning cycle World class commissioning competencies Part 5 What support does NICE offer commissioners? 30 Implementation support NHS Evidence Part 6 How can you get involved? 34 Take part in the development of guidance Get involved with the NICE implementation support programme Develop local networks Let us keep you informed
6 Part 1 Why has NICE produced this guide? NICE has produced this guide to help you. NICE guidance provides you with robust, evidence-based, cost-effective national recommendations that you can use to inform local decision-making in commissioning health services and interventions that promote health and wellbeing. You can use NICE and NHS Evidence accredited guidelines to support the focus on quality and productivity and ensure optimal care, which can help you release resources or generate savings. You can use our implementation tools when planning, prioritising and commissioning services. This guide will help you use our guidance and tools in your commissioning process. Who is this guide for? This guide is for people involved in commissioning health and social care services and public health programmes within the NHS and partner organisations in England, but the principles may be useful for commissioners throughout the UK.
7 Joint commissioners and people working in local authorities may find this guide useful to inform partnership working and joint planning. Providers of health and social care services and public health programmes may also find this guide useful to understand the benefits of delivering services in line with NICE guidance. What is this guide for? This guide is to support commissioners in developing systems and processes that embed NICE guidance into commissioning, and to signpost sources of further information and practical help. You can use it to develop long-term plans and strategies for commissioning that are evidence based and focused on the needs of your population. The guide can also support day-to-day commissioning. NICE is aware of the financial context in which commissioning and planning is currently taking place within the NHS. We are undertaking a number of initiatives to support the NHS to implement our guidance while achieving financial balance. More information is available at Why has NICE produced this guide?
8 Part 2 How can PCT boards support the use of NICE guidance? Why should PCT boards support the use of NICE guidance? World class commissioning emphasises the responsibility of PCT boards to manage risks and demonstrate their input into strategic planning and performance management. Working within financial constraints and focusing on quality and productivity, how can PCT boards ensure organisations perform at their best, while meeting the requirements of the Care Quality Commission and world class commissioning? Making NICE guidance an integral part of the commissioning process can help PCT boards fulfil these responsibilities and meet national requirements and standards. Having the right processes in place can provide assurance that robust decision-making underpins the planning of services for your local community. This includes cases for investment and decommissioning ineffective interventions.
9 Boards can also use NICE guidance and implementation tools to inform work with stakeholders (including local authorities), set priorities and assess the value and anticipated outcomes of implementing the guidance. This will improve the effectiveness and quality of services, and promote the health and wellbeing of the population. Part 4 of this guide provides further information on how NICE s guidance and implementation support tools can help PCT boards meet world class commissioning competencies. There is a statutory obligation for PCTs to make funding available for treatments recommended in NICE s technology appraisal guidance. Clinicians are expected to take all NICE s guidance fully into account in the treatment of patients. The Audit Commission recommends that organisations develop a sustainable approach to financial planning, use horizon scanning to identify forthcoming guidance, and assess the cost impact of implementing guidance 1. This requires effective financial planning to make the best use of resources, and good links between commissioners, providers, financial planners and clinicians. More information about meeting legal requirements and effective financial planning is available at benefitsofimplementation 1 Audit Commission (2005) Managing the financial implications of NICE guidance. London: Audit Commission. Available from How can PCT boards support the use of NICE guidance?
10 How can PCT boards assess whether NICE guidance is being used? Are systems in place to actively monitor when new NICE guidance is published? What impact will implementing guidance have, and how does this shape your vision for the health and wellbeing of the local population? How is implementation built into business planning processes and who needs to be involved? Are all commissioning decisions within the organisation, including joint, collaborative and specialised commissioning arrangements, based on NICE guidance and accredited information provided by NHS Evidence? (See Part 5 for further information.) How is this demonstrated in strategic planning and business Use the NICE forward planner to develop a 6-month agenda of topics for discussion. You can assess your current position and plan to implement guidance and commission services. More information is available in Part 5 and at implementationtools processes? Are the Professional Executive Committee and local clinicians involved in this process? Are providers of health and social care services and public health programmes delivering services and interventions based on NICE guidance? If not, how are you ensuring they are moving towards compliance? What improvement measures should be introduced? How can the board be assured that there is an improvement in the quality and effectiveness of provision? What impact will this have on your ability to meet vital signs and world class commissioning commitments? More information on how to benefit from using NICE guidance is included in Part 3 of this guide. 10 How can PCT boards support the use of NICE guidance?
11 Case study: NHS North Yorkshire and York finding the mission for commissioning NHS North Yorkshire and York used NICE guidance alongside local data to provide an evidence base to inform future priorities and strategic planning. The Trust wanted to go beyond needs assessment to needs addressment. It used the principles of programme budgeting to identify existing expenditure, together with local data, background information and evidence (for example, NICE guidance) to use resources to maximum effect. Public health reports, published annually by Directors of Public Health, are an ideal vehicle for publicising NICE guidance and citing the evidence for specific topics. said Dr Peter Brambleby, Director of Public Health, NHS North Yorkshire and York. The latest report from our PCT does just this, putting evidence alongside data and background information to help us move services forward. The annual report of the Director of Public Health began with these questions about North Yorkshire and York: What are the health needs, inequalities and trends? Where does the NHS money go and how can we plan for greater efficiency? How will we deliver the topics in Healthy ambitions and demonstrate world class commissioning? What work was the public health directorate engaged in last year? Challenges: what is the mission for commissioning in the year ahead? The Trust s first Joint Strategic Needs Assessment combined background information (populations, determinants, diseases, trends and inequalities), narrative (patients stories and ideas) and evidence (NICE public health guidance and clinical guidelines). The Trust also set out what it proposed to do, which linked to the Local Area Agreement and its targets. The Joint Strategic Needs Assessment was themed around topics that the public said were most important to them: being healthy, being safe, quality of life, making a positive contribution, economic wellbeing, and access to high-quality services. The Trust also linked the topics to the themes of the NHS Next Stage Review, known locally as Healthy ambitions. How can PCT boards support the use of NICE guidance? 11 11
12 Part 3 How can NICE guidance help you? Why use NICE guidance in commissioning? We provide national guidance for the NHS, local authorities, and other public organisations on the promotion of good health and the prevention and treatment of ill health. In order to make sure our guidance represents value for money, we use the best available evidence and health economic modelling to weigh up benefits and costs. Using NICE guidance can help commissioners in the following ways: Providing evidence-based recommendations about clinically-effective and cost effective treatments and interventions to improve outcomes for your population. Providing recommendations that can be used to inform local ambitions for quality improvement, for example, within the Commissioning for Quality and Innovation (CQUIN) payment framework. Commissioners should use existing contract levers to ensure providers are implementing guidance. For more information, see Managing the financial impact of NICE guidance on page
13 Providing clear recommendations to support the NHS in working with partner organisations to develop joint commissioning in the form of joint strategic partnerships, Joint Strategic Needs Assessments and Local Area Agreements. Enabling organisations to demonstrate that they comply with registration requirements assessed by the Care Quality Commission, world class commissioning competencies, the assurance framework, and Comprehensive Area Assessments. Providing assurance for PCT boards, practice-based commissioning organisations, Overview and Scrutiny Committees, elected members and the public, that robust evidence underpins decision-making. The NHS is being asked to focus on ensuring quality care while at the same time planning for a challenging financial situation. To help support the NHS in these new, challenging circumstances, NICE has produced a list of what we estimate to be cost-saving guidance. For more information, see benefitsofimplementation Providing evidence to support cases for investment and the decommissioning of services, helping to make efficiencies in the system, for example identifying How can NICE guidance help you? 13 13
14 treatments or interventions that do not add value, and thresholds below which they are not cost effective. Helping you optimise the use of people (healthcare professionals) and resources through implementing recommendations for evidence-based treatments and care. Supporting business planning by ensuring that you are basing your local priority setting, planning and agreed outcomes on robust evidence. Providing a framework for working with clinicians and practice-based commissioners to identify opportunities for service redesign. Providing evidence-based information that can inform discussions with patients, carers and the public. Also see Strategic planning on page How can NICE guidance help you?
15 Case study: North East Lincolnshire Care Trust Plus using NICE guidance to support investment in cost-effective treatments and interventions The NICE clinical guideline on long-acting reversible contraception (LARC) identified the clinical effectiveness and cost effectiveness of LARC methods, and identified potential cost savings linked with reducing unplanned pregnancies. North East Lincolnshire Care Trust Plus undertook a baseline assessment of the use of LARC across north east Lincolnshire, mapping locations of provision of LARC and the percentage uptake of contraception in the eligible female population. This assessment demonstrated that there were marked variations in the uptake of LARC across practice-based commissioning groups. This review identified the following points: There were gaps in training, which represented a barrier to increasing the number of providers of services offering LARC. There were no referral pathways between providers and non-providers of LARC. There was a lack of promotion of contraception to both women and GPs, which could improve knowledge of LARC methods. As a result the PCT developed an action plan to address the key areas of concern and improve access and uptake of LARC methods. This led to an increase in the use of LARC, and the PCT is continuing to work to improve this. Long-acting reversible contraception. NICE clinical guideline 30 (2005). Available from How can NICE guidance help you? 15 15
16 What guidance does NICE produce? We produce the following types of guidance: Clinical guidelines recommendations about the treatment and care of people with specific diseases or conditions in the NHS 2. Health technologies (technology appraisal guidance and interventional procedures guidance) guidance on the use of new and existing medicines, treatments and procedures in the NHS 3. Public health guidance guidance on ways of helping people improve their health and reduce their risk of illness 4. The booklet NICE: our guidance sets the standard for good healthcare explains more about NICE and the types of guidance we produce (available from NICE s topic selection process The Department of Health asks NICE to develop clinical guidelines, based on the best available evidence, on the appropriate treatment and care of people with specific diseases and conditions. We are also asked to produce guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector. Key areas for consideration when 2 Clinical guidelines apply to England and Wales, and may also apply to Northern Ireland under special arrangements. 3 Technology appraisal guidance applies to England and Wales and is reviewed locally in Scotland and Northern Ireland. Interventional procedures guidance applies to England, Wales, Scotland and Northern Ireland. Interventional procedures guidance makes recommendations on the safety and efficacy of a procedure. The guidance does not cover whether or not the NHS should fund a procedure. Decisions about funding are taken by local NHS bodies. 4 Public health guidance applies to England only. 16 How can NICE guidance help you?
17 identifying topics for clinical guidelines and public health guidance include the burden of disease, the cost impact on the NHS or the public sector, policy importance, and whether there is inappropriate variation in practice across the country. The Department of Health also asks us to develop guidance, in the form of technology appraisals, where it would be beneficial to have clarity about the value of a new or existing drug, treatment or intervention. Key areas for consideration when identifying topics for technology appraisals include the number of people affected, the severity of the disease, the cost impact on the NHS, and the extent to which a new drug or treatment claims measurable therapeutic benefit over currently available NHS treatments. Anyone can notify a procedure for consideration by the Interventional Procedures Programme, although the main source of notifications is clinicians and healthcare professionals. Notifications are usually made via our website. To fall within the Programme s remit, the procedure must involve an incision or a puncture or entry into a body cavity, or use ionising, electromagnetic or acoustic energy, should be available in the NHS or private sector, and be either not yet considered standard clinical practice or be a standard clinical procedure with new questions about its safety or efficacy. If NICE guidance is available, it is an indication that the subject is an important issue that affects your population. Using NICE guidance to assess needs and set priorities As a commissioner, you need to anticipate our guidance in advance of its publication and assess it against the national, regional and local priorities identified in your 5-year strategic plan or Joint Strategic Needs Assessment. You need to estimate the resource and cost impact, and prepare the health economy to support implementation of the guidance. How can NICE guidance help you? 17 17
18 Managing the financial impact of NICE guidance Reference costs have been collected annually since 1988 and show the average cost to the NHS of providing a service. They are generally used to inform the national payment by results (PbR) tariff. If NICE guidance is published after the reference cost data have been collected, the impact of guidance is not included. Therefore to ensure the PbR tariff is sufficient, NICE and the Department of Health s tariff setting team identify the impact of the guidance and adjust the tariff accordingly. For more information on the financial impact of NICE guidance, go to Using quality standards in your commissioning process A quality standard is a set of specific, concise statements that: act as markers of high-quality, cost-effective patient care across a pathway or clinical area, covering treatment or prevention are derived from the best available evidence are produced collaboratively with the NHS and social care, along with their partners and patients. The Department of Health identified a role for NICE in developing independent quality standards. The National Quality Board has been created to offer transparent advice on what the priorities should be for clinical standard setting by NICE. The standards will include qualitative statements and quantitative measures (linked with national indicators where they exist). NICE works collaboratively with other organisations and consults stakeholders during field testing of quality standards. 18 How can NICE guidance help you?
19 Topic Evidence source Required Generated Guidance recommendations Quality standards Distilled into Produced Quality measures Overview of the quality standards process The role of the Care Quality Commission The Care Quality Commission is the regulator for health and social care. All organisations providing health and social care services have to register the services they provide with the Care Quality Commission and demonstrate that they are meeting the standards required. If it is shown that an organisation is not providing safe and effective care, as a result of not implementing NICE guidance or complying with technology appraisals, the Care Quality Commission will take appropriate action proportionate to the risk posed to people who use the services. Commissioners will be able to use NICE quality standards as markers of high-quality care, and patients and the public will see clear statements of what they can expect from services. The Care Quality Commission will take account of how organisations are using quality standards to ensure patients receive high-quality care. How can NICE guidance help you? 19 19
20 Part 4 NICE guidance and the commissioning cycle NICE guidance and accredited information provided by NHS Evidence should be considered at every stage of the commissioning cycle. The commissioning cycle was described by the Department of Health in 2006 and has become a recognised model for commissioning NHS services and care. NICE provides a variety of support tools that can help during different stages of the commissioning cycle, including business and financial planning. For example, we develop costing tools to estimate the resource impact of commissioning a new drug or treatment. 20
21 Assess needs Review current service provision Decide priorities Manage performance (quality, performance, outcomes) Strategic planning Specifying outcomes and procuring services Managing demand and performance Patient and public involvement Specify services Shape structure of supply Reproduced with the kind permission of the Department of Health Clinical decisionmaking Manage demand and ensure appropriate access to care NICE guidance and the commissioning cycle 21 21
22 Strategic planning Our guidance and support tools can help you determine local priorities for long-term strategic commissioning and service provision by: helping you assess whether current provision meets your population s needs providing you with robust, evidence-based recommendations to underpin decisions where there are competing priorities helping inform your Joint Strategic Needs Assessment with partner organisations by providing you with information on incidence, prevalence and the burden of disease, helping you benchmark the actual level of disease in your population. NICE guidance and other accredited sources of information can help you meet the requirements of vital signs, Local Area Agreements and national indicator sets. For more information, go to and Commissioners can use our audit support to identify gaps in service provision, monitor improvements and determine where service redesign or decommissioning is required. These tools can be used within the CQUIN payment framework. Part 5 of this guide provides an overview of some of the support tools that can be found at usingguidance 22 NICE guidance and the commissioning cycle
23 Case study: East Midlands Specialised Commissioning Group/ East Midlands Cancer Network assessing local priorities East Midlands Specialised Commissioning Group/East Midlands Cancer Network carried out a review of all new cancer treatments likely to be licensed and/or reviewed by NICE in the subsequent 18 months. Previously, cancer treatments would have been reviewed by individual PCTs, generally led by clinicians with little input from commissioners, resulting in ad hoc implementation and putting enormous financial pressures on PCTs requiring resources to be re-allocated. The new process enabled a proactive, planned and unified response across the PCTs, ensuring that patients had equitable access to cancer treatments. Clinicians compiled an initial list of all cancer treatments that they considered would have the greatest benefit for patients. The list was reviewed by commissioners and clinicians, alongside the projected financial impact, to identify treatments that would use funding to maximum effect and be considered value for money. This resulted in a prioritised list of treatments for funding in the next financial year, which was adopted by all participating PCTs. To ensure that treatments were prescribed according to agreed criteria, commissioning policies were developed for the treatments, and monitoring forms were introduced to supplement audit data. Clinicians have found the process beneficial in knowing when investment would be available. This has facilitated forward planning for patient pathways, the establishment of new clinics, and patient involvement in the process. NICE guidance and the commissioning cycle 23 23
24 Specifying outcomes and procuring services Local priorities and expectations will determine the changes that you want to make. Being explicit about the benefits you want to achieve will enable you to demonstrate return on investment. NICE guidance and implementation support tools can help you shape local services and improve outcomes by: outlining the key components of a service identifying interventions that are cost effective identifying interventions that are not effective, which you may need to decommission providing a common standard for prevention, treatment and care, which can be used to develop consistency across different service providers identifying which healthcare professionals or other providers, for example third sector providers, might be able to deliver the service, or where a change in the structure of supply may be appropriate identifying the skills or training that may be required to deliver a high-quality service. 24 NICE guidance and the commissioning cycle
25 Case study: Rotherham weight management service Around one third of children and two thirds of adults in Rotherham are overweight or obese. NHS Rotherham used NICE guidance on obesity to design an obesity model and commission a weight management service. The service is outcome based (successful weight loss) and uses multicomponent interventions, as recommended in the NICE guideline. The model of care is tiered, with separate pathways for adults and children. It will offer support for weight management, including preventive interventions, to at least 2000 children, young people and their families and a further 2000 adults over 3 years. People will move up and down through the tiers and be encouraged to self manage. Interventions for children include Carnegie clubs (fun, locally-based programmes) and residential camps. Adults are offered interventions ranging from community weight management programmes to bariatric surgery. A multidisciplinary team of healthcare professionals provides specialist and one-to-one advice for children, adults and families. The programme includes access to anti-obesity medication as recommended in the NICE guideline. Adults prescribed anti-obesity medication are offered the lifestyle support needed to ensure that the medication is effective in the long term. Pharmacotherapy is also being offered to young people for the first time. If successful, the investment will pay for itself by preventing obesity and associated ill health in the local population. Obesity. NICE clinical guideline 43 (2006). Available from NICE guidance and the commissioning cycle 25 25
26 Managing demand and performance NICE guidance and implementation support tools can help you by: setting criteria and thresholds for treatment or interventions, to help you ensure appropriate access to services or programmes, and manage service demand enabling fair and equal access to care, treatments and interventions for your populations and communities clarifying care pathways to highlight where services should be integrated, and to inform referral management and clinical decision-making identifying when early diagnosis and intervention can deliver improved patient outcomes offering evidence-based opportunities for health promotion and prevention. Patient and public involvement The NHS needs to become more responsive to the patients who use it, and more accountable to the citizens who fund it. Primary care trusts, strategic health authorities and NHS trusts have a duty to make arrangements to involve and consult patients and the public in service planning and operation, and in the development of proposals for changes. Through choice and an increased voice, local people and patients can influence commissioning to ensure that health and social care services are matched to their needs and preferences. Commissioners need to ensure that patients and communities are involved throughout the commissioning cycle, so local GP practice patient forums, local authority user groups, local involvement networks (LINks) patient representatives, the third sector 26 NICE guidance and the commissioning cycle
27 (including community organisations) and PCT patient and user engagement mechanisms can inform commissioning. NICE guidance and implementation support tools can support this process in the following ways: Providing clear information about treatment, care and interventions that support self-management, raise awareness, and empower patients and the public. This can also help manage expectations and support joint decision-making. Providing an opportunity for public consultation. Demonstrating that the local health community is basing commissioning decisions on robust, evidence-based guidance to improve health and reduce health inequalities. Feedback about patients and carers experiences can help to inform needs assessments and strategic planning, and support experience-based design. Community engagement to improve health (NICE public health guidance 9) contains recommendations for commissioners, including those in local authorities and the third and private sectors, on working with and involving communities in decisions about healthcare. Building NICE guidance into your commissioning cycle Many organisations already have NICE leads or managers to support the implementation of NICE guidance locally. PCTs may wish to consider working with the NICE leads or managers to ensure that NICE guidance is a core part of the commissioning process. Some areas have developed systems that ensure their local implementation strategy is integral to commissioning. NICE guidance and the commissioning cycle 27 27
28 World class commissioning competencies NICE guidance and support tools can help you meet the following world class commissioning competencies: No. World class commissioning competency 4 Collaborate with clinicians Lead continuous and meaningful engagement of a broad range of clinicians to inform strategy and drive quality, service design and efficient and effective use of resources. 5 Manage knowledge and assess need Manage knowledge and undertake robust and regular needs assessments that establish a full understanding of current and future local health needs and requirements. 6 Prioritise investment of all spend Prioritise investment of all spend in line with different financial scenarios and according to local needs, service requirements and the values of the NHS. 7 Stimulate the market Effectively stimulate the market to meet demand and secure required clinical, and health and wellbeing outcomes. How NICE can help commissioners Recommendations from NICE guidance can provide a robust evidence base to inform discussions with clinicians and provide opportunities for innovation, redesign and implementing effective treatments. NICE recommendations provide national standards, which may be important in identifying where there is a variation with best practice. This can be used to benchmark data on local services and compare performance and outcomes. NICE provides an evidence base to support modelling and comparisons between best practice and return on previous investments and interventions. NICE recommendations can help define outcomes and quality specifications for providers. Guidance can identify key stakeholders. This can be useful to inform the development of a mixed economy of provision across sectors, including provision for public health programmes. 28 NICE guidance and the commissioning cycle
29 No. World class commissioning competency 8 Promote improvement and innovation Promote and specify continuous improvements in quality (for example CQUIN, indicators for quality improvement) and outcomes, through clinical and provider innovation and configuration. 9 Secure procurement skills Secure procurement skills that ensure robust and viable contracts. 10 Manage the local health system Effectively manage systems and work in partnership with providers to ensure contract compliance and continuous improvements in quality and outcomes. 11 Ensuring efficiency and effectiveness of spend How NICE can help commissioners NICE guidance provides recommendations on effective interventions for prevention and treatment, which can help you implement continual improvement in the quality and outcomes of services. NICE recommendations provide national standards, which can help you define service requirements, enabling improvements through negotiation in service quality and value for money. You can use NICE recommendations to inform discussions about provider performance and quality of care. For example, you can include the implementation of NICE recommendations in plans to improve provider performance, which could be monitored using NICE audit support. NICE guidance identifies treatments and interventions that are cost effective, and treatments and interventions of low value that are not recommended. You can review current spend on these areas. NICE guidance and the commissioning cycle 29 29
30 Part 5 What support does NICE offer commissioners? Implementation support A range of implementation support tools are available on our website ( These will help you commission evidence-based services and assess the impact of implementing NICE guidance locally. How to guides We have a number of How to guides, which advise the NHS and local authorities about using NICE guidance to improve patient care and wellbeing. Forward planner This summarises published and forthcoming NICE guidance. It explains which sectors are likely to be affected, estimates the potential cost impact, and notes what the impact may be on PbR. 30
31 Commissioning guides Topic-specific commissioning guides and associated tools are web-based resources to support effective local commissioning of evidence-based care for patients. They offer detailed practical information on key clinical and service-related issues, and an interactive commissioning tool to help you estimate and inform the level of service needed locally, as well as the cost of local commissioning decisions. Costing tools Costing tools help assess the financial impact of implementing NICE guidance. They comprise a national costing report and a flexible Excel costing template, which you can amend to estimate local costs and savings. Audit support Audit support tools help people carry out baseline assessments and monitor any subsequent activities. They are available in formats that can be integrated into local audit systems. Slide sets Slide sets are presentations (with notes) that can help to raise awareness of new guidance at an early stage. They highlight the key priorities for implementation and offer questions that can be used in discussion. They can be adapted to suit local needs. What support does NICE offer commissioners? 31 31
32 Bespoke support tools We develop bespoke tools to help implement NICE guidance. Such tools include implementation advice (providing help with action planning), guides to resources (highlighting tools, resources and examples of good practice), commissioning factsheets, algorithms, planning checklists, patient leaflets, posters and template letters. You may find them useful to feed into your local commissioning and planning processes. Quick reference guides Quick reference guides summarise the guidance recommendations and list the key priorities for implementation, which will help you to identify priorities for your local area. They often contain clinical pathways, which can help in planning changes to local services. Understanding NICE guidance These leaflets explain what NICE has said. They are written for patients, carers and those with little medical knowledge, and can be used in local patient information leaflets or any other suitable publication. They are available for clinical guidelines and health technology guidance. Optimal practice review: recommendation reminders Optimal practice review: recommendation reminders help commissioners to identify areas of practice that are no longer recommended. They may help support a local case for disinvestment. 32 What support does NICE offer commissioners?
33 Implementation consultants NICE has a field-based team of implementation consultants who work with organisations to help to put our guidance into practice. Each consultant works with NHS, local authority and other organisations in their area, ensuring regular interaction with NICE stakeholders and facilitating implementation of NICE guidance. to find your local consultant. Shared Learning database The Shared Learning database provides examples from organisations implementing NICE guidance and the lessons they have learnt. NHS Evidence NHS Evidence is a service that provides quick and easy access to a range of best practice, clinical and non-clinical information to help you make informed decisions about treatments and resources as part of the commissioning process. If you have an Athens account you can also access subscription journals. NHS Evidence also has a robust accreditation scheme that identifies trusted sources of guidance with an accreditation mark, increasing your confidence in the information available. NHS Evidence for Commissioning is a specialist collection relating to commissioning. It includes information about commissioning competencies, service sectors, datasets and case studies. Information on key topic areas, such as financial management and involving patients in commissioning, is updated regularly. Commissioners can also keep up to date with significant new evidence through a monthly e-bulletin Eyes on evidence. Subscription is free via the portal, see What support does NICE offer commissioners? 33 33
34 Part 6 How can you get involved? Take part in the development of guidance You can suggest topics for consideration by NICE, register to be involved in the development of guidance, or take part in the consultation process for a guidance topic that interests you your input is valued. To find out how, visit Get involved with the NICE implementation support programme You can also get involved in a number of our implementation support programmes by sending your comments or joining advisory or reference groups, for example: Talk to your local NICE implementation consultant. to find your local consultant. Get involved with the NICE commissioning programme. the commissioning team at Get involved in our implementation programme us at 34
35 Register at enewsletter for monthly e-alerts from NICE Have you got some tips to share with other organisations on implementing NICE guidance? Perhaps you ve come up with an innovative way to commission services based on a particular set of NICE recommendations. Why not submit an example to the Shared Learning database? Go to Develop local networks Work with your NICE manager or lead to support implementation of NICE guidance through the services you commission. Pass the guidance on to local partner organisations and networks, using our quick reference guides and implementation support tools. Link with your stakeholder organisations to disseminate guidance and determine the impact of implementing the guidance in your area. Let us keep you informed Sign up to NICE monthly e-alerts, which will tell you when guidance is being published. How can you get involved? 35 35
36 N2020 ISBN k 1P Nov 09 National Institute for Health and Clinical Excellence MidCity Place, 71 High Holborn, London WC1V 6NA Level 1A, City Tower, Piccadilly Plaza, Manchester M1 4BD
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
Agenda item 9 ii) Northumberland, Tyne and Wear NHS Foundation Trust Board of Directors Meeting Meeting Date: 25 October 2017 Title and Author of Paper: Clinical Effectiveness (CE) Strategy update Simon
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY BUSINESS PLAN 2011/2012 to 2014/15 FINAL National Institute for Health and Clinical Excellence 1 Business Plan FINAL Contents
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
NHS Bradford Districts CCG Commissioning Intentions 2016/17 Introduction This document sets out the high level commissioning intentions of NHS Bradford Districts Clinical Commissioning Group (BDCCG) for
briefing November 2011 Issue 227 Payment by Results in mental health A challenging journey worth taking Key points Commissioners and providers support the introduction of Payment by Results for adult mental
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
Issue date: July 2007 Acutely ill patients in hospital Recognition of and response to acute illness in adults in hospital Developed by the Centre for Clinical Practice at NICE Contents Key priorities for
Recommendations 1, 2, 3 1. That the Minister for Health and Social Services should, as a matter of priority, identify means by which a more strategic, coordinated and streamlined approach to medical technology
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean firstname.lastname@example.org HEE North School of Pharmacy
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
Consultation Our next phase of regulation A more targeted, responsive and collaborative approach Cross-sector and NHS trusts December 2016 Contents Foreword...3 Introduction...4 1. Regulating new models
the voice of NHS leadership briefing February 211 Issue 214 Efficiency in mental health services Supporting improvements in the acute care pathway Key points As part of the current focus on improving quality,
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
INTRODUCTION TO THE UK PUBLIC HEALTH REGISTER ROUTE TO REGISTRATION FOR PUBLIC HEALTH PRACTITIONERS This introduction consists of: 1. Introduction to the UK Public Health Register 2. Process and Structures
Vale of York Clinical Commissioning Group Governing Body Public Health Services 2 February 2017 Summary 1. The purpose of this report is to provide the Vale of York Clinical Commissioning Group (CCG) with
Welsh Affairs Committee. Purpose: The Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales. Contact: Nesta Lloyd Jones, Policy and Public Affairs
JOB DESCRIPTION Job Title: Grade: Team: Accountable to: Joint Commissioning Manager for Older People s Residential Care and Nursing Homes HAY 14 / AfC 8b (indicative) Partnership Commissioning Team Head
Discussion paper on the Voluntary Sector Investment Programme Overview As important partners in addressing health inequalities and improving health and well-being outcomes, the Department of Health, Public
Appendix 1 Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance Policy Title: Executive Summary: Policy on the dissemination, implementation and monitoring of national
South Yorkshire & Bassetlaw Health and Care Working Together Partnership Memorandum of Understanding Agreement Final Draft June 2017 1 Title Drafting coordinator Target Audience Version V 0.3 Memorandum
This document is uncontrolled once printed. Please check on the CCG s Intranet site for the most up to date version COMMISSIONING FOR QUALITY FRAMEWORK Document Title: Commissioning for Quality Framework
POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and
Issue date: October 2009 Guide to the multiple technology appraisal process Guide to the multiple technology appraisal process Issued: October 2009 This document is one of a series describing the processes
Improving Healthy Lifestyles Pilot Site Evaluation Report Key findings The health check is a good opportunity to deliver brief lifestyle behaviour advice to patients, most of which is recalled three months
MEMORANDUM OF UNDERSTANDING THE PROVISION OF PUBLIC HEALTH ADVICE TO NHS COMMISSIONING IN ROTHERHAM 1. Parties to the agreement: Rotherham Metropolitan Borough Council ( the Council ) NHS Rotherham Clinical
The guidelines manual Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
Corporate CCG CO01 Access and Choice Policy Version Number Date Issued Review Date V1: 28/02/2013 31/08/2014 Prepared By: Consultation Process: Governance Lead, NHS South of Tyne and Wear Information Governance
the voice of NHS leadership briefing DECEMBER 2008 ISSUE 172 The operating framework for the NHS in England 2009/10 Key points No new national targets. National priorities are the same as last year. but
A Participation Standard for the NHS in Scotland Standard Document Scottish Health Council Scottish Health Council 2010 Published August 2010 ISBN 1-84404-916-7 You can copy or reproduce the information
South Yorkshire and Bassetlaw Accountable Care System PMO Office: 722 Prince of Wales Road Sheffield S9 4EU 0114 305 4487 23 June 2017 Letter to: South Yorkshire and Bassetlaw Accountable Care System Chief
Corporate CCG: CO01 Access and Choice Policy Version Number Date Issued Review Date V2 21 January 2016 January 2018 Prepared By: Consultation Process: NECS Commissioning Manager CCG Head of Corporate Affairs.
Direct Commissioning Assurance Framework England NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information Nursing Policy Commissioning Development Finance Human Resources
Date: 24 September 2014 ATTACHED: Wolverhampton Public Health Effective Commissioning Strategy 2014-2019 Executive summary. Wolverhampton Public Health Effective Commissioning Strategy 2014-2019 Executive
Communication & Engagement Strategy Stoke-on-Trent & North Staffordshire Clinical Commissioning Groups 2017 2021 The NHS belongs to all of us. It is there to improve our health and wellbeing, supporting
Knowledge and Skills for Social Workers in Adult Services Government response to the Consultation on the Knowledge and Skills Statement for Social Workers in Adult Services March 2015 Title: Government
NORTH WALES CLINICAL STRATEGY PRIMARY CARE & COMMUNITY SERVICES SBAR REPORT February 2010 Situation The Primary Care & Community Services workstream had been tasked with answering the following question:
NHS Rotherham Management Executive 31 May 2011 NHS Rotherham Board 6 June 2011 Equality Delivery System This report has been informed by a briefing note from the SHA Contact Details: Lead Director: Sarah
Learning from adverse events Learning and improvement summary November 2014 Healthcare Improvement Scotland 2014 Published November 2014 You can copy or reproduce the information in this document for use
Corporate plan 2014 2017 Moving towards better regulation Page 1 Protecting patients and the public through efficient and effective regulation Page 2 Contents Chair and Chief Executive s foreword 4 Introduction
National Institute for Health and Clinical Excellence The guidelines manual January 2009 The guidelines manual About this document This document describes the methods used in the development of NICE guidelines.
Welsh Government Response to the Report of the National Assembly for Wales Public Accounts Committee Report on Unscheduled Care: Committee Report We welcome the findings of the report and offer the following
Summary report Primary care www.health.org.uk A review of the effectiveness of primary care-led and its place in the NHS Judith Smith, Nicholas Mays, Jennifer Dixon, Nick Goodwin, Richard Lewis, Siobhan
The Commissioning of Hospice Care in England in 2014/15 July 2014 Help the Hospices. Company limited by guarantee. Registered in England & Wales No. 2751549. Registered Charity in England and Wales No.
Statement of Arrangements and Guidance on Patient and Public Participation in Commissioning NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing
REPORT TO CROYDON CLINICAL COMMISSIONING GROUP GOVERNING BODY Meeting in Public 30 October 2012 Title: CROYDON CCG AND CROYDON PUBLIC HEALTH MEMORANDUM OF UNDERSTANDING Lead Director Report Author Contact
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
Appendix-2016-59 Borders NHS Board SCOTTISH BORDERS HEALTH & SOCIAL CARE INTEGRATED JOINT BOARD UPDATE ON THE DRAFT COMMISSIONING & IMPLEMENTATION PLAN Aim To bring to the Board s attention the Scottish
How CQC regulates: NHS and independent ambulance services Provider handbook March 2015 The Care Quality Commission is the independent regulator of health and adult social care in England. Our purpose We
Utilisation Management The Utilisation Management team has developed a reputation over a number of years as an authentic and clinically credible support team assisting providers and commissioners in generating
North West COPD Report Nov 2011 Working together to improve respiratory care in the North West 1 Contents Introduction foreword by NW Respiratory Leads... 3 4 reasons why COPD is important in the North
Improving Health Services for Carers A carer is someone who, without payment, looks after or provides help and support to somebody who could not manage otherwise due to age, physical or mental illness,
Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 5 September 2013 Report Sponsor: Rachel Potts Chief Operating Officer Report Author: Melanie Cooper and
Admiral Nurse Standards Foreword The last few years have seen many new government directives and policy initiatives. Plans for enhancing the quality of care in the NHS have been built around national standards
Equality and Health Inequalities Strategy 1 Schematic of the Equality and Health Inequality Strategy Improving Lives: People and Patients Listening and Learning Gaining Knowledge Making the System Work
WOLVERHAMPTON CLINICAL COMMISSIONING GROUP Corporate Parenting Board Agenda Item No. 7 Health Services for Looked After Children Annual Report September 2014 -August 2015 Date of Meeting: 23 rd Feb 2016.
Title Document Details Clinical Audit Policy Trust Ref No 1538-31104 Main points this document covers This policy details the responsibilities and processes associated with the Clinical Audit process within
Education and Training Committee, 9 June 2016 Improving patient safety through education and training - Report by the Commission on Education and Training for Patient Safety Executive summary and recommendations
Northern Ireland Peer Review of Cancer MDTs EVIDENCE GUIDE FOR LUNG MDTs CONTENTS PAGE A. Introduction... 3 B. Key questions for an MDT... 6 C. The Review of Clinical Aspects of the Service... 8 D. The
NHS Nene and NHS Corby Clinical Commissioning Groups QUALITY STRATEGY 2017-2021 Approved: By the Joint Quality Committee on 11 April 2017 Ratified: By the NHS Corby Clinical Commissioning Group on 25 April
NHS Digital Academy Experience and Advice from Cohort 1 Zainab Hussain Lead Pharmacist Clinical Informatics Lewisham and Greenwich NHS Trust Sarah Thompson Head of EPR Clinical Deployment Stockport NHS
Knowledge & Information Repository Care Planning and Diabetes Supporting, Improving, Caring January 2012 Reader Page Title Knowledge & Information Repository Care Planning and Diabetes Author Dr Louise
Appendix 3 Dudley Clinical Commissioning Group Commissioning Intentions Black Country Partnerships NHS Foundation Trust 2013/2014 1 Strategy and Context Our Commissioning Intentions indicate to our current
Report to Governing Body 19 September 2018 Report Title Author(s) Governing Body/Clinical Lead(s) Management Lead(s) CCG Programme Purpose of Report Summary NHS Lambeth Clinical Commissioning Group (CCG)
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 13 Date of Meeting:..27 th October 2017.. TITLE OF REPORT: Looked After Children Annual Report 2016-2017 AUTHOR: Christine Dixon,
briefing December 2011 Issue 231 Developing an outcomes-based approach in mental health Key points A new Mental Health Network report explores the issue of outcome measurement in mental health. The report
Shine 2013 final report Project title My Discharge a proactive case management for discharging patients with dementia Organisation name Royal Free London NHS foundation rust Project completion: March 2014
BARIATRIC SURGERY SERVICES POLICY Please note that all Central Lancashire Clinical Commissioning Policies are currently under review and elements within the individual policies may have been replaced by
NHS Summary Care Record Guide for GP Practice Staff NHS Summary Care Record Guide for GP Practice Staff v1.2 October 2012 Table of Contents 1 Introduction to this guide...3 2 Overview of the Summary Care
Commissioning for Value insight pack NHS England Gateway ref: 00525 Contents Introduction: the call to action The approach Where to look using indicative data Phase 2 & 3 Why act what benefits do the population
CASE STUDY NHS North Yorkshire and York Managing long term conditions through redesigning the care pathways and integrating telehealth North Yorkshire and York The challenge Strategic plans NHS North Yorkshire
Securing excellence in commissioning for the Armed Forces and their families March 2013 Securing excellence in commissioning for the Armed Forces and their families First published: March 2013 Page 2 of
4 Year Patient and Public Involvement Strategy 2015-18 Contents Page(s) 1. Introduction - 2. Summary of the patient and public involvement strategy 2015-18 - 3. Definitions of involvement and best practice
Clinical Excellence (NICE) Guidance VELINDRE NHS TRUST Trust Procedure Black 21 PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE Lead: Lisa Heydon-Mann